CareRx Aktie

CareRx Corporation (TSX:CRRX) has reported its financial results for the fourth quarter ended December 31, 2022, during which a key success was winning a multi-year contract to provide pharmacy services to residents in multiple seniors living facilities in Atlantic Canada. "Our 2022 results reflect the exceptional progress we have made in growing our national presence and expanding our leadership position over the past three years," said David Murphy, president and chief executive officer of CareRx in the results statement. » Mehr auf proactiveinvestors.com

Canaccord Genuity (TSX:CF, LSE:CF) analysts have reiterated their ‘Buy' rating for CareRx Corporation (TSX:CRRX) but reduced their price target after the Canadian healthcare company raised equity financing.  CareRx announced on January 18 it completed a bought deal offering and closed the first tranche of a concurrent private placement for aggregate gross proceeds of around $12.1 million. » Mehr auf proactiveinvestors.com

CareRx Corporation (TSX:CRRX) announced that it has completed its bought deal public offering and closed the first tranche of the concurrent private placement for aggregate gross proceeds of around $12.1 million. The Canadian healthcare company issued an aggregate of 2,998,000 shares under the offering, including 35,000 shares issued as a result of the partial exercise of the over-allotment option granted to the syndicate of underwriters led by Cormark Securities Inc, at a price of $2.70 per share for aggregate gross proceeds of approximately $8.1 million. » Mehr auf proactiveinvestors.com